Related Experiment Video

Updated: May 28, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

Cell-penetrating peptides as antifungals towards Malassezia sympodialis

T Holm1, J Bruchmann, A Scheynius

  • 1Department of Neurochemistry, Stockholm University, Sweden. tina_holm79@hotmail.com

Letters in Applied Microbiology
|October 26, 2011
PubMed
Abstract

Insights

Certain cell-penetrating peptides (CPPs) and antimicrobial peptides (AMPs) effectively inhibit Malassezia sympodialis growth. These non-toxic peptides offer potential new treatments for skin conditions like eczema and dandruff.

Area of Science:

  • Microbiology
  • Dermatology
  • Biochemistry

Background:

  • Malassezia sympodialis is a commensal yeast implicated in skin disorders like atopic eczema (AE), seborrhoeic eczema (SE), and dandruff.
  • Antimicrobial peptides (AMPs) and cell-penetrating peptides (CPPs) are investigated for their potential therapeutic applications.

Purpose of the Study:

  • To evaluate the efficacy of various AMPs and CPPs in inhibiting the growth of Malassezia sympodialis.
  • To assess the safety of these peptides on human keratinocytes.

Main Methods:

  • Microdilution assays were employed to determine the antifungal activity of 21 different peptides.
  • Plate counting was used to quantify colony-forming units and assess fungicidal activity.
  • Human keratinocytes were treated with peptides to evaluate potential membrane damage.

Main Results:

  • Five CPPs and one AMP demonstrated fungicidal activity against Malassezia sympodialis at submicromolar concentrations.
  • No significant membrane damage was observed on human keratinocytes following peptide treatment.
  • The study identified specific peptides with potent antifungal properties against this yeast.

Conclusions:

  • Several CPPs exhibit non-toxic, growth-inhibitory effects on Malassezia sympodialis.
  • These findings suggest that specific CPPs and AMPs could be developed as novel therapeutic agents for AE, SE, and dandruff.
  • This research marks the first identification of peptides as antifungal agents against Malassezia sympodialis, warranting further mechanistic studies.

More Related Videos

Infecting Mice with Malassezia spp. to Study the Fungus-Host Interaction06:19

Infecting Mice with Malassezia spp. to Study the Fungus-Host Interaction

Published on: November 6, 2019

Live-cell Imaging of Fungal Cells to Investigate Modes of Entry and Subcellular Localization of Antifungal Plant Defensins08:39

Live-cell Imaging of Fungal Cells to Investigate Modes of Entry and Subcellular Localization of Antifungal Plant Defensins

Published on: December 24, 2017

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...